Heike Göhler

Title: Heike Göhler: Innovator in Diagnostic Methods

Introduction

Heike Göhler is a prominent inventor based in Bochum, Germany. He has made significant contributions to the field of diagnostics, particularly in the identification and characterization of high-affinity binders and marker sequences. With a total of 3 patents to his name, Göhler's work has the potential to impact medical diagnostics significantly.

Latest Patents

One of Göhler's latest patents is a method for diagnosing high-affinity binders and marker sequences. This invention relates to a novel approach for diagnosing antibodies or autoantibodies, along with the identification and selection of marker sequences for diagnostic use. The method includes a singleplex assay that utilizes a panel of discovered marker sequences to detect high-affinity binders using a single signal. Another notable patent is focused on the diagnosis of neuromyelitis optica (NMO). This invention outlines a method for diagnosing and risk stratification of NMO through the determination of artificial aquaporin-4 peptides from a body sample of a patient. It also includes a kit and new artificial aquaporin-4 peptides.

Career Highlights

Heike Göhler is associated with Protagen AG, a company that specializes in innovative diagnostic solutions. His work at Protagen AG has allowed him to develop cutting-edge methods that enhance the accuracy of medical diagnostics.

Collaborations

Göhler collaborates with talented professionals in his field, including colleagues such as Stefan Müllner and Petra Rengers. Their combined expertise contributes to the advancement of diagnostic technologies.

Conclusion

Heike Göhler's innovative contributions to diagnostic methods demonstrate his commitment to improving medical science. His patents reflect a deep understanding of the complexities involved in diagnosing conditions like neuromyelitis optica and the development of high-affinity binders. His work continues to pave the way for advancements in the field of diagnostics.